Market research
BBZA.F BB Biotech AG
F EUR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- Not available
- Analyst target
- 60.8418
- Dividend yield
- 3.9%
- Beta
- 0.67
Community
Investor discussion
1 comment
Sign in to join the BBZA.F discussion.
5 years, 5 months ago
BB Biotech AG is currently in a long term uptrend where the price is trading 11.6% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.7.
Based on the above factors, BB Biotech AG gets an overall score of 2/5.